Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

ARNOTT

Showing results (871-880 of 1,193) with videos related to

Pageof 120
Sort By:
BMJ Open|May 16, 2022
Managing Unusual Sensory Experiences in People with First-Episode Psychosis (MUSE FEP): a study protocol for a single-blind parallel-group randomised controlled feasibility trialRobert Dudley, Guy Dodgson, Stephanie Common, et al.
Human Molecular Genetics|July 7, 2007
Investigation of NOD1/CARD4 variation in inflammatory bowel disease using a haplotype-tagging strategyJohan Van Limbergen, Elaine R Nimmo, Richard K Russell, et al.
Proteomics|June 11, 2016
Quantitative phosphoproteomic analysis of the PI3K-regulated signaling networkFlorian Gnad, Jeffrey Wallin, Kyle Edgar, et al.
United European Gastroenterology Journal|February 21, 2023
Multiple infliximab biosimilar switches appear to be safe and effective in a real-world inflammatory bowel disease cohortBeatriz Gros, Nikolas Plevris, Nathan Constantine-Cooke, et al.
Nature Reviews. Cardiology|June 16, 2026
Role of systemic and epicardial adipose tissue in cardiometabolic diseaseShaun Khanna, Gurkeerat Mann, Aditya Bhat, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1995
Results of a randomized trial comparing MVPP chemotherapy with a hybrid regimen, ChlVPP/EVA, in the initial treatment of Hodgkin's diseaseJ A Radford, D Crowther, A Z Rohatiner, et al.
Investigational New Drugs|May 26, 2010
A phase II study of 2-methoxyestradiol (2ME2) NanoCrystal® dispersion (NCD) in patients with taxane-refractory, metastatic castrate-resistant prostate cancer (CRPC)Michael R Harrison, Noah M Hahn, Roberto Pili, et al.
Cancer Letters|December 1, 1979
Patterns of benzo[alpha]pyrene metabolism in normal human pulmonary alveolar macrophagesM V Marshall, T L McLemore, R R Martin, et al.
European Heart Journal|December 5, 2019
Sex differences in heart failureCarolyn S P Lam, Clare Arnott, Anna L Beale, et al.
Current Problems in Cancer|August 1, 1981
Biologic markers in cancer diagnosis and treatmentE D Holyoke, G E Block, E Jensen, et al.
Pageof 120

Showing results (871-880 of 1,193) with videos related to

Sort By:
Pageof 120
BMJ Open|May 16, 2022
Managing Unusual Sensory Experiences in People with First-Episode Psychosis (MUSE FEP): a study protocol for a single-blind parallel-group randomised controlled feasibility trialRobert Dudley, Guy Dodgson, Stephanie Common, et al.
Human Molecular Genetics|July 7, 2007
Investigation of NOD1/CARD4 variation in inflammatory bowel disease using a haplotype-tagging strategyJohan Van Limbergen, Elaine R Nimmo, Richard K Russell, et al.
Proteomics|June 11, 2016
Quantitative phosphoproteomic analysis of the PI3K-regulated signaling networkFlorian Gnad, Jeffrey Wallin, Kyle Edgar, et al.
United European Gastroenterology Journal|February 21, 2023
Multiple infliximab biosimilar switches appear to be safe and effective in a real-world inflammatory bowel disease cohortBeatriz Gros, Nikolas Plevris, Nathan Constantine-Cooke, et al.
Nature Reviews. Cardiology|June 16, 2026
Role of systemic and epicardial adipose tissue in cardiometabolic diseaseShaun Khanna, Gurkeerat Mann, Aditya Bhat, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1995
Results of a randomized trial comparing MVPP chemotherapy with a hybrid regimen, ChlVPP/EVA, in the initial treatment of Hodgkin's diseaseJ A Radford, D Crowther, A Z Rohatiner, et al.
Investigational New Drugs|May 26, 2010
A phase II study of 2-methoxyestradiol (2ME2) NanoCrystal® dispersion (NCD) in patients with taxane-refractory, metastatic castrate-resistant prostate cancer (CRPC)Michael R Harrison, Noah M Hahn, Roberto Pili, et al.
Cancer Letters|December 1, 1979
Patterns of benzo[alpha]pyrene metabolism in normal human pulmonary alveolar macrophagesM V Marshall, T L McLemore, R R Martin, et al.
European Heart Journal|December 5, 2019
Sex differences in heart failureCarolyn S P Lam, Clare Arnott, Anna L Beale, et al.
Current Problems in Cancer|August 1, 1981
Biologic markers in cancer diagnosis and treatmentE D Holyoke, G E Block, E Jensen, et al.
Pageof 120